Principales conclusions et analyse des parts de marché du traitement de la bronchopneumopathie chronique obstructive (BPCO) d'ici 2025-2031
Chronic Obstructive Pulmonary Disease Treatment Market Report Analysis
Chronic Obstructive Pulmonary Disease Treatment Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Abbott
- AstraZeneca
- BoehringerIngelheim Pharmaceuticals, Inc.
- CHIESI Farmaceutici S.p.A.
- GlaxoSmithKline plc
- Mylan N.V.
- Novartis AG
- Orion Corporation
- Sunovion Pharmaceuticals, Inc.
Regional Overview
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et centrale
- Moyen-Orient et Afrique
Market Segmentation
By Classe de médicaments
- bronchodilatateurs
- association
- inhibiteurs de la phosphodiestérase de type 4
- mucocinétique
- corticostéroïdes
- autres
By Canal de distribution
- pharmacies en ligne
- pharmacies hospitalières
- pharmacies de détail
By Géographie
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et Centrale
Get Free Sample For